Journal of Hypertension
Journal of Hypertension is a journal indexed in SJR in Physiology and Internal Medicine with an H index of 198. It has an SJR impact factor of 1,097 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,097.
Journal of Hypertension focuses its scope in these topics and keywords: pressure, blood, treatment, hypertension, hypertensive, stroke, vascular, type, risk, ischemic, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
1,097
H-index
198
Docs (year)
317
Docs 3y
908
Total refs
11443
Cites 3y
2569
Citable 3y
736
Cites/Doc 2y
2.65
Ref/Doc
36.1
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?
View moreVascular effect of bevacizumab
View moreCarotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness
View moreCardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure
View moreBrain Gai2-subunit protein-gated pathways are required to mediate the centrally evoked sympathoinhibitory mechanisms activated to maintain sodium homeostasis
View moreBlunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity
View moreBlood pressure changes after renal denervation are more pronounced in women and nondiabetic patients
View moreBlood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension
View moreAtrial fibrillation, arterial hypertension, and primary aldosteronism
View moreAssociation of tumor necrosis factor-a with early target organ damage in newly diagnosed patients with essential hypertension
View moreAssociation of suboptimal blood pressure control with body size and metabolic abnormalities
View moreAssessment of body position to quantify its effect on nocturnal blood pressure under ambulatory conditions
View moreArterial mechanics and wave reflection with antihypertensive therapy
View more4C.03
View moreAngiotensin II-induced over-activation of p47phox in fibroblasts from hypertensives: which role in the enhanced ERK1/2 responsiveness to angiotensin II?
View moreAngiotensin II and norepinephrine release: interaction and effects on the heart
View moreAn age-related decline in endothelial function is not associated with alterations in l-arginine transport in humans
View moreAltered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment
View moreAbsolute and relative changes in carotid intima???media thickness and atherosclerotic plaques during long-term antihypertensive treatment
View moreA role for cardiac mast cells in the pathogenesis of hypertensive heart disease
View moreA randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients
View moreA prospective study of hypertension and the incidence of kidney stones in men
View moreA new twist on hypertension-causing mutations in the epithelial Na+ channel
View moreA frameshift mutation of beta subunit of epithelial sodium channel in a case of isolated Liddle syndrome
View more